Alcohol Effects on Drinking Behavior
(CSDP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates why some young adults drink excessively and what sustains this behavior. Researchers are testing how different beverages affect drinking behavior, including non-alcoholic drinks, caffeine, low or heavy alcohol doses, and diphenhydramine (an allergy medicine). They aim to determine if responses to these drinks can predict future drinking habits. Ideal participants drink alcohol at least once a week and frequently engage in binge drinking. Participants must be available for in-person sessions in Chicago and follow-up interviews. As an unphased trial, this study offers a unique opportunity to contribute to understanding drinking behaviors and potentially influence future interventions.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study excludes individuals with major medical or psychiatric disorders, it might imply that participants should not be on medications for such conditions.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that caffeine is usually safe for healthy adults, but it can be harmful to some individuals. Mixing caffeine with alcohol may lead to increased alcohol consumption, potentially intensifying its effects.
For small amounts of alcohol, such as 0.4 grams per kilogram of body weight, research indicates it can affect attention, particularly in moderate drinkers. This amount is often used in studies to understand alcohol's impact and is usually well-tolerated, though it can still alter behavior.
Larger amounts of alcohol, like 0.8 grams per kilogram, are linked to binge drinking. Studies confirm this amount can cause noticeable changes in behavior and bodily reactions. While generally safe for study participants, it can lead to significant effects typical of heavy drinking.
Diphenhydramine, an ingredient in Benadryl, can cause drowsiness and other side effects. When combined with alcohol, these effects may worsen, leading to serious issues like fainting or loss of coordination. This combination is usually not recommended due to the increased risk.
Each of these substances has different safety levels. Always consider personal health and consult a healthcare professional before joining a study.12345Why are researchers excited about this trial?
Researchers are excited about the Chicago Social Drinking Project trial because it explores how various beverage compositions affect drinking behavior differently. Unlike traditional treatments that focus solely on counseling or medication to manage alcohol consumption, this trial examines the impact of beverages containing different substances, like caffeine and diphenhydramine, alongside varying alcohol strengths. By understanding how these components influence drinking habits, researchers hope to gather insights that could lead to more personalized and effective strategies for managing alcohol consumption.
What evidence suggests that this trial's treatments could be effective?
This trial will compare the effects of various beverages on drinking behavior. Research has shown that mixing caffeine with alcohol, one of the experimental arms in this trial, can lead to increased consumption and stronger perceived effects of alcohol. Studies suggest that caffeine might make individuals feel less drunk, prompting them to drink more. Another arm involves low-alcohol drinks, which, while potentially safer than consuming large amounts, still carry risks. Low doses of alcohol can influence mood and behavior, yet they remain risky. Consuming large amounts of alcohol, as tested in the heavy alcohol dose arm, is associated with numerous health problems, and most heavy drinkers do not have alcohol dependence. Mixing diphenhydramine (found in Benadryl) with alcohol, another experimental arm, can exacerbate side effects like drowsiness and coordination issues. These substances have varying effects and risks, which can influence drinking behavior.12367
Who Is on the Research Team?
Andrea C King, PhD
Principal Investigator
University of Chicago
Are You a Good Fit for This Trial?
This trial is for adults aged 21-65 who weigh between 110-210 lbs and drink alcohol at least once a week, including weekly 'binge' drinking episodes. They must be reachable for follow-ups for two years and able to attend two sessions at the University of Chicago. People with major medical or psychiatric disorders, or alcohol/substance dependence cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Participants undergo baseline testing to examine subjective and objective response differences to alcohol and other substances
Treatment
Participants consume various beverages including placebo, caffeine, low and heavy alcohol doses, and diphenhydramine to assess responses
Follow-up
Participants are monitored through longitudinal follow-up interviews to determine future consumption patterns
What Are the Treatments Tested in This Trial?
Interventions
- Chicago Social Drinking Project
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator